{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Patients receive placebo oral solution (swish, gargle for 30 seconds, and slowly swallow) on day 1.","id":"OG000","title":"Placebo"}],"populationDescription":"Only patients who submitted data on patient preference are evaluable for this outcome measure. Since none of the patients crossed over to the optional phase of the study, this secondary outcome could not be analyzed.","reportingStatus":"POSTED","timeFrame":"At initial Day 1 dose and Day 3 crossover dose.","title":"Patient Preference for Continued Therapy at Initial Dose and Crossover","type":"SECONDARY"}